AstraZeneca PLC (AZN) And Daiichi Pharmaceutical Co., Ltd. Sign $100M Nexium Deal
10/29/2010 7:43:44 AM
More...
|
Daiichi Pharmaceutical Co., Ltd. Names Dr. Jay Feingold Vice President, Medical Affairs Bolsters Company's Expertise in Areas of Oncology and Hematology
2/11/2010 10:50:04 AM
More...
|
Daiichi Pharmaceutical Co., Ltd. Profit Forecast Disappoints, Shares Dive
5/12/2009 7:40:26 AM
More...
|
Eli Lilly and Company (LLY) Release: Prasugrel Receives Positive Opinion from the European Committee for Medicinal Products for Human Use (CHMP)
12/19/2008 10:45:30 AM
More...
|
Ranbaxy Laboratories Says Daiichi Pharmaceutical Co., Ltd. Deal on Track, Shares Rise
7/16/2008 6:41:01 AM
More...
|
Daiichi Sankyo, Inc. Grants Priority Review for Daiichi Pharmaceutical Co., Ltd., Daiichi Pharmaceutical Co., Ltd. Drug, Prasugrel Investigational Antiplatelet Agent
2/22/2008 6:31:58 AM
More...
|
Daiichi Pharmaceutical Co., Ltd. Receives Import Approval For Ultrasound Contrast Medium Sonazoid
10/26/2006 6:31:53 PM
More...
|
Daiichi Pharmaceutical Co., Ltd. Selects MediData Solutions For Cost-Effective, Multilingual Clinical Trials
10/24/2006 11:24:52 AM
More...
|
Daiichi Pharmaceutical Korea To Become Wholly Owned Subsidiary Of Daiichi Pharmaceutical Co., Ltd.
10/10/2006 9:45:17 AM
More...
|
YM BioSciences (YM.TO) Licenses Monoclonal Antibody, Nimotuzumab, To Daiichi Pharmaceutical (JPN) For Japan; CIMYM BioSciences Inc. To Receive Up-Front Payment Of $14.5 Million
7/31/2006 10:53:12 AM
More...
|
|